Sitemap
April 14, 2018 Articles
Filter by Available Specialty
- 5 articles discussing the CV effects of caffeine
- 8-weeks of Zepatier may effectively treat HCV genotype 4
- Abstinence does not reduce HCC risk in alcoholic-related cirrhosis
- Alan S. Crandall receives inaugural Chang Humanitarian Award at ASCRS
- Alcohol, cannabis use have no impact on HCV cure rates
- American Association for Cancer Research names academy fellows
- Budesonide decreases serum alkaline phosphatase in PBC
- Childhood obesity project identifies successful strategies in 4 US communities
- Cooperation among specialties key to advancing ophthalmology
- ELAD shows promise in alcoholic hepatitis biomechanical response
- Femtosecond laser-assisted keratectomy suitable for corneal scarring
- Galectin-3 inhibitor improves hepatic ballooning in NASH
- Glaukos files patent lawsuit against Ivantis
- Grünenthal, KU Leuven collaborate to develop novel, non-opioid pain treatment
- ILC 2018 offers hope in autoimmune liver disease: PBC, PSC, hepatitis
- Patients, dermatologists differ in perception of patient’s psoriasis
- Study finds potential benefits of probiotics for patients with ESRD
- Systemic immunotherapy becoming more popular in ophthalmology
- Trained rats more successful in diagnosing TB than standard tests
- Value of prophylaxis for cirrhotic bacterial infections requires review
- VIDEO: Novaliq seeks entry into US dry eye market
- Web-based lifestyle intervention as effective as group programs for fatty liver
- Women on HRT, birth control safely, effectively treated HCV with Zepatier